Bicocca Open Archive

Logo unimib boa
OKOLICSANYI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.885
EU - Europa 2.620
AS - Asia 2.566
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 384
AF - Africa 80
OC - Oceania 10
Totale 13.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.506
SG - Singapore 910
CN - Cina 642
IT - Italia 598
DE - Germania 390
RU - Federazione Russa 352
BR - Brasile 347
CA - Canada 336
VN - Vietnam 308
SE - Svezia 298
HK - Hong Kong 261
IE - Irlanda 211
GB - Regno Unito 179
UA - Ucraina 175
IN - India 129
FR - Francia 91
DK - Danimarca 68
AT - Austria 67
BD - Bangladesh 58
FI - Finlandia 53
AR - Argentina 44
TR - Turchia 44
IQ - Iraq 31
ES - Italia 30
NL - Olanda 26
MX - Messico 25
SA - Arabia Saudita 23
ZA - Sudafrica 23
BE - Belgio 21
KR - Corea 21
JP - Giappone 20
EC - Ecuador 19
CO - Colombia 18
PL - Polonia 16
PH - Filippine 15
PK - Pakistan 15
VE - Venezuela 13
ID - Indonesia 12
MA - Marocco 11
MY - Malesia 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 7
KE - Kenya 7
NP - Nepal 7
PE - Perù 7
PY - Paraguay 7
TN - Tunisia 7
AU - Australia 6
ET - Etiopia 6
IR - Iran 6
JM - Giamaica 6
JO - Giordania 6
TW - Taiwan 6
AZ - Azerbaigian 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
BO - Bolivia 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
EU - Europa 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MN - Mongolia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
TH - Thailandia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
LY - Libia 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
ZM - Zambia 2
A1 - Anonimo 1
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
Totale 12.621
Salva come PNG Salva come JPEG
Città #
Ann Arbor 862
Ashburn 662
Singapore 517
Woodbridge 462
San Jose 370
Fairfield 339
Houston 301
Chandler 271
Hong Kong 258
Toronto 241
Wilmington 232
Frankfurt am Main 215
Dublin 204
Milan 173
Dearborn 166
New York 158
Jacksonville 157
Seattle 140
Cambridge 133
Council Bluffs 104
Dallas 97
Santa Clara 96
Los Angeles 94
Beijing 93
Princeton 81
Ho Chi Minh City 80
Hanoi 74
The Dalles 67
Chicago 65
Vienna 65
Nanjing 64
Rome 55
Shanghai 54
Altamura 39
Buffalo 39
Lawrence 38
Columbus 35
Lauterbourg 34
São Paulo 33
Moscow 32
Orem 28
Lachine 26
Guangzhou 24
Nanchang 23
Shenyang 23
Tianjin 23
Boardman 22
Phoenix 21
Helsinki 20
San Diego 20
Washington 19
Dong Ket 18
Boston 17
Atlanta 16
Da Nang 16
Fremont 16
Munich 16
Ottawa 16
Tokyo 16
Brooklyn 15
Brussels 15
Hefei 15
Jinan 14
Johannesburg 14
Rio de Janeiro 14
Haiphong 13
London 13
Manchester 13
Warsaw 13
Andover 12
Baghdad 12
Dhaka 12
Kunming 12
Lissone 12
Brasília 11
Changsha 11
Edmonton 11
Seoul 11
Denver 10
Mountain View 10
Nürnberg 10
Jeddah 9
Kuala Lumpur 9
Mexico City 9
Montreal 9
New Delhi 9
Newark 9
Sacramento 9
Salt Lake City 9
San Francisco 9
Zhengzhou 9
Chennai 8
Falls Church 8
Hangzhou 8
Hebei 8
Hải Dương 8
Jiaxing 8
Mumbai 8
Philadelphia 8
Valencia 8
Totale 8.015
Salva come PNG Salva come JPEG
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 542
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 520
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 488
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 424
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 416
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 382
Health related quality of life in chronic liver diseases 360
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 360
Health Related Quality of Life in the Major Liver Conditions 346
The impact of liver disease on the health-related quality of life 344
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 343
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 341
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 335
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 334
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 326
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 325
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 320
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 314
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 312
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 312
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 312
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 311
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 309
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 309
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 302
Difference in health related quality of life of chronic liver diseases and general population 300
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 298
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 293
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center 288
Liver-allocation policies for patients affected by HCC in Europe 284
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 283
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 277
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 271
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 271
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 263
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 261
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 258
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 244
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 236
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 203
Totale 13.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022369 0 0 0 57 16 41 19 41 26 37 38 94
2022/20231.054 106 369 88 90 56 139 21 73 68 3 31 10
2023/2024647 21 27 15 49 58 213 127 24 40 6 5 62
2024/20251.504 86 160 115 47 123 59 99 49 196 260 109 201
2025/20263.909 472 158 303 325 422 187 514 150 315 393 383 287
2026/2027911 83 160 389 279 0 0 0 0 0 0 0 0
Totale 13.017